濮阳东方妇科线上预约(濮阳东方医院男科看阳痿价格收费低) (今日更新中)

BEIJING, May 16 (Xinhua) -- An initial ruling by China's Ministry of Commerce said Monday that European Union (EU) members have subsidized potato starch exports to China, hurting the interests of China's domestic industries.China will impose an anti-subsidy provision of the tariff on potato starch products effective from May 19, the ministry said in a statement on its website. The rate will range between 7.7 percent and 11.19 percent, depending on the subsidy margin, according to the statement.The initial ruling accused several EU companies, including France's Roquette Freres and Netherland's AVEBE, of receiving subsidies.China launched an anti-subsidy investigation into potato starch imports from the EU on August 30, 2010 at the request of the China Starch Industry Association. This was China's first-ever anti-subsidy probe into imports from the EU.China had earlier decided to impose anti-dumping tariffs ranging from 12.6 percent to 56.7 percent on EU potato starch products. The new tariffs were effective from April 19.

LOS ANGELES, April 6 (Xinhua) -- Freeze-dried strawberries may play a role in the prevention of esophageal cancer, a new study suggests."Strawberries may be an alternative or work together with other chemopreventive drugs for the prevention of esophageal cancer," said lead researcher Tong Chen, M.D., Ph.D., assistant professor, division of medical oncology, department of internal medicine at the Ohio State University.Study findings were presented at the ongoing 102nd annual meeting of the American Association for Cancer Research (AACR) in Orlando, Florida, according to the American Association for the Advancement of Science (AAAS) on Wednesday."We concluded from this study that six months of eating strawberries is safe and easy to consume. In addition, our preliminary data suggests that strawberries can decrease histological grade of precancerous lesions and reduce cancer- related molecular events," said Chen, who is also a member of the Molecular Carcinogenesis and Chemoprevention Program in the Ohio State University Comprehensive Cancer Center.The study involved a group of participants who consumed 60 grams of freeze-dried strawberries daily for six months and completed a dietary diary chronicling their strawberry consumption.The researchers obtained biopsy specimens before and after strawberry consumption. The results showed that 29 out of 36 participants experienced a decrease in histological grade of the precancerous lesions during the study.Using freeze-dried strawberries was important because by removing the water from the berries, they concentrated the preventive substances by nearly 10-fold, Chen said.Esophageal cancer is the third most common gastrointestinal cancer and the sixth most frequent cause of cancer death in the world, she noted.Chen and her team are studying esophageal squamous cell carcinoma (SCC) which makes up 95 percent of cases of esophageal cancer worldwide. China, where this study took place, has the highest incidence of esophageal SCC, according to the AAAS.In a previous study, Chen and colleagues found that freeze- dried strawberries significantly inhibited tumor development in the esophagus of rats. Based on these results, they embarked on a Phase Ib trial that included participants with esophageal precancerous lesions who were at high risk for esophageal cancer."Our study is important because it shows that strawberries may slow the progression of precancerous lesion in the esophagus," Chen said.But she said they need to test this in randomized placebo- controlled trials in the future.

BEIJING, Feb. 12 (Xinhua) -- The Chinese government has reiterated a strict ban on hepatitis B tests during pre-employment physical examinations as many companies reportedly violated rules to require hepatitis B tests for job applicants.In a statement released Saturday, the Ministry of Health said that no health institutions are allowed to provide hepatitis B checks as part of pre-employment physical tests regardless of whether the examinees provide consent or not.On Feb. 10, 2010, the Ministry of Health, the Ministry of Education and the Ministry of Human Resources and Social Security jointly issued a circular demanding the cancellation of the hepatitis B tests during the health checks for school enrollment and employment nationwide.However, according to a survey released this week, which was conducted by the non-profit Beijing Yirenping Center, some 61.1 percent of the 180 state-run companies surveyed included hepatitis B checks in their pre-employment physical examinations.More surprisingly, 63 companies said that they would never consider hepatitis B carriers for a job or were reluctant to hire such people.Yu Fangqiang, the principal of the Yirenping Center, said that such violations mainly resulted from light punishment for violations and some health institutions' desire for profits.According to the survey, employers would only be fined between thousands to tens of thousands of yuan if they lose their lawsuits for bias against hepatitis B carriers.Meanwhile, a worker will spend a lot of time, energy and money to file a lawsuit and collect evidence in order to win.Liu Xiaonan, an associate professor with the China University of Political Science and Law, called on the government to hammer out a particular law and set up a special committee to investigate discrimination cases in order to ensure the rights of workers.In the statement released Saturday, the health ministry also ordered a careful investigation of all cases of hepatitis B discrimination, and promised that violators would be exposed and punished in accordance with laws and regulations.Medical tests show that hepatitis B virus can only be transmitted from mother to child during childbirth or by contact with the blood or other body fluids of an infected person.

BEIJING, Feb.11 (Xinhua) -- Representatives from different sectors have given feedback on drafts of the government work report and China's economic and social development blueprint for the next five years, the State Council, China's cabinet, said Friday.Premier Wen Jiabao chaired five seminars from Jan. 20 to 27, at which representatives of various sectors of society were invited to voice their views on the documents, according to a State Council statement.The 12th five-year program, or the national development plan for 2011 to 2015, and the government work report will be delivered for review at the plenary session of the National People's Congress (NPC), China's top legislature, in March.Experts from social economic organizations along with those from science and technology, education, health, culture and sports circles attended the meetings, as well as members of non-communist parties.Participants at the seminars agreed on the framework and main content of the documents. They also gave some suggestions and proposed a couple of revisions to the report and the development plan.Most suggestions focused on China's economic restructuring, income distribution adjustment, modern agricultural development, scientific innovation, reform of the yuan exchange rate formation mechanism, property market regulation and affordable housing construction, and further improvement in education and medical care system.The forums also invited 11 grass-roots representatives, including farmers, technicians, and owners of small businesses, who raised suggestions to boost farmland irrigation construction, train more technicians, and help with the development of small and medium enterprises.Wen said the feedback will be "of great help" when revising both the government work report and 12th five-year plan, as well as to the work of the government.

CHENGDU, May 8 (Xinhua) -- As a brand-name herbal capsule for cardiovascular disease in China, Di'ao Xinxuekang only needs to wait for another 15 years before reaching the EU market."The Dutch medical supervisors have recognized it as a qualified drug, but we still lack the evidence of 15-year presence in the EU market," said Ji Jianxin, a research manager with the drug's developer Di'ao Group based in southwest China's Sichuan Province.Di'ao, one of the largest Traditional Chinese Medicine (TCM) manufacturers, has been quite depressed, as many other TCM enterprises in China, by a European Union directive on traditional herbal medicinal products fully implemented from the beginning of this month.The directive requires that all herbal medicinal products, must obtain a medical license from any EU member state before it can be allowed in the EU market.It introduced a so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to be licensed, including Chinese and Indian ones.However, not a single Chinese herbal medicinal product has been granted the license so far, mainly due to the prohibitive registration cost and lack of required evidence to prove the product had a 30-year history of safe use, including 15 years in the EU.With a history of more than 2,000 years, TCM did not enter into the EU market until mid-1990s, and it has been imported into the EU and sold to European customers as food supplements instead of drugs.Most Chinese producers and importers did not reserve the customs papers a decade ago, thus unable to prove the 15-year use of their products in European markets.While TCM's globalization won't be doomed by one single EU directive as TCM export value to EU only takes up 14 percent of the total in 2010, experts and industry insiders still have had serious concerns about its future."Most TCM even don't have standardized labels that can help consumers to find out its origin," said Xian Sheng, from the China Association of TCM Export Companies.

来源：资阳报